Shah, Nirali N <br/><br/>
Vincristine Sulfate Liposomes Injection (VSLI, MarqiboŽ): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias.  [electronic resource] 

 -  Pediatric blood & cancer  Jun 2016 
 - 997-1005 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.25937  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Liposomes<br/>Male<br/>Maximum Tolerated Dose<br/>Neoplasms--drug therapy<br/>Registries<br/>Vincristine--administration & dosage<br/>Young Adult